Leap Therapeutics Inc. buy Raymond James
Start price
14.11.23
/
50%
€1.37
Target price
14.11.24
€16.21
Performance (%)
91.24%
End price
15.11.24
€2.62
Summary
This prediction ended on 15.11.24 with a price of €2.62. With a performance of 91.24% the BUY prediction by Raymond_James was a big success. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Leap Therapeutics Inc. | 10.929% | 10.929% | 140.237% |
| iShares Core DAX® | -1.424% | 8.918% | 7.311% |
| iShares Nasdaq 100 | 3.274% | 16.275% | 36.651% |
| iShares Nikkei 225® | 1.745% | 16.239% | 46.602% |
| iShares S&P 500 | 1.447% | 10.913% | 27.166% |
Comments by Raymond_James for this prediction
In the thread Leap Therapeutics Inc diskutieren
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at Raymond James from $18.50 to $17.50. They now have an "outperform" rating on the stock.
Ratings data for LPTX provided by MarketBeat
In the thread Trading Leap Therapeutics Inc.
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten